Heritage Foods sets Oct 16 date for Q2FY27 earnings conference call
- Heritage Foods Limited schedules earnings call for October 16, 2026
- Call discusses Q2 and H1 FY27 financial performance at 11:00 am IST
- Management team including CEO Srideep Kesavan will participate
- Hosted by Go India Advisors with global dial-in options

*this image is generated using AI for illustrative purposes only.
Heritage Foods Limited has scheduled its earnings conference call for Friday, October 16, 2026, at 11:00 am IST. The session will cover the company's financial results for the second quarter and first half of fiscal year 2027.
The event is hosted by Go India Advisors. Investors and analysts can access the call via universal dial-in numbers provided in the invitation. Pre-registration is recommended to avoid wait times during the live session.
Key Participants
The management team engaging with investors includes:
- N Brahmani, Executive Director
- Sambasiva Rao, Whole Time Director
- Srideep Kesavan, Chief Executive Officer
- A Prabhakara Naidu, Chief Financial Officer
- J Samba Murthy, Chief Operating Officer
- Umakanta Barik, Company Secretary & Compliance Officer
- Brij Mohan, CEO of Heritage Nutrivet
Call Logistics
Participants are advised to dial in at least 5 to 10 minutes prior to the scheduled start time. The following numbers are available for access:
| Region | Dial-in Number |
|---|---|
| India (Universal) | +91 22 6280 1456 / +91 22 7115 8804 |
| USA (Toll Free) | 1866 746 2133 |
| UK (Toll Free) | 0808 1011 573 |
| Singapore (Toll Free) | 800 101 2045 |
| Hong Kong (Toll Free) | 800 964 448 |
This intimation was filed pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Historical Stock Returns for Heritage Foods
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.28% | -0.07% | +4.85% | +28.14% | -19.67% | +71.04% |
How might the inclusion of Heritage Nutrivet's CEO in the call signal a strategic shift or increased focus on the animal health segment?
What specific guidance will management provide regarding raw material cost inflation and its impact on margins for the remainder of FY27?
Are there any announced plans for capacity expansion or new product launches that could drive growth beyond the current H1 FY27 performance?


































